期刊文献+

DLK1-DIO3印记区域的miRNAs与疾病的发生

The miRNAs Within The DLK1-DIO3 Imprinted Region Involved in Disease Pathogenesis
下载PDF
导出
摘要 哺乳动物的基因组以发育调控模式进行转录,生成长的和短的非编码RNAs(non-coding RNA,ncRNAs).ncRNAs占到人类转录组的98%,与生物体进化复杂程度显著相关.MicroRNAs(miRNAs)是目前研究比较透彻的,长度大约为20~24个核苷酸的ncRNAs,其通过与靶基因mRNA的结合在转录后水平负调控基因的表达.人类基因组中一个最大的miRNA簇位于14号染色体(14q32)的DLK1-DIO3印记区域,包括了54个miRNAs.这些miRNAs通过参与调节重要的信号通路在许多病理过程中发挥作用.充分了解DLK1-DIO3印记区域中这个大的miRNA簇,在病理生理过程中的重要性将有助于为相关疾病的治疗提供新的策略.本文比较深入地分析了DLK1-DIO3印记区域中的miRNAs在调控组织动态平衡以及多种癌症发生中的作用,同时对其潜在的临床应用价值进行了讨论. The mammalian genome is transcribed in a developmentally regulated manner, generating RNA transcripts ranging from long to short non-coding RNA(ncRNAs). NcRNAs represent up to 98% of the human transcriptome and have an association with organism complexity. MiRNAs are the best-studied class of ncRNAs.MiRNAs are approximately 22 nucleotides long and act as gene negative regulators at a post-transcription level. In humans, the DLK1-DIO3 genomic region, located on human chromosome 14(14q32), contains one of the largest microRNA clusters with 54 miRNAs in the genome. Many of these miRNAs are differentially expressed by modulating important signaling pathways in several pathologic processes and various cancers. A better understanding of the pathophysiologic importance of the DLK1-DIO3 domain-containing microRNA cluster may contribute to innovative therapeutic strategies in a range of diseases. Here we present an in-depth review of the role the microRNAs of DLK1-DIO3 region may play in controlling tissue homeostasis and in the pathogenesis of mostly cancer. The potential clinical implications of these miRNAs are also discussed.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2017年第4期316-325,共10页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(31372312)~~
关键词 DLK1-DIO3印记区域 MIRNA 转录调控通路 肿瘤 潜在的生物学标记 DLK1-DIO3 imprited domain miRNA transcriptional regulatory pathways cancer potential biomarks
  • 相关文献

参考文献2

二级参考文献26

  • 1Sun X, Chen W, Chen Z, Wen D, Zhao D, He Y. Populationbasedcase-control study on risk factors for esophageal cancer infive high-risk areas in China. Asian Pac J Cancer Prev 2010; 11:1631-1636 [PMID: 21338208].
  • 2Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk factors foresophageal cancer development. Asian Pac J Cancer Prev 2011;12: 2461-2466 [PMID: 22320939].
  • 3Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 2012; 62: 283-298 [PMID:22987332 DOI: 10.3322/caac.21153].
  • 4Zhu ZJ, Hu Y, Zhao YF, Chen XZ, Chen LQ, Chen YT. Earlyrecurrence and death after esophagectomy in patients withesophageal squamous cell carcinoma. Ann Thorac Surg 2011; 91:1502-1508 [PMID: 21354552 DOI: 10.1016/j.athoracsur.2011.01.007].
  • 5Griffin SM, Burt AD, Jennings NA. Lymph node metastasisin early esophageal adenocarcinoma. Ann Surg 2011; 254:731-76; discussion 731-76; [PMID: 21997815 DOI: 10.1097/SLA.0b013e318236048b].
  • 6Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs.Science 2005; 309: 1519-1524 [PMID: 16141061].
  • 7Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M.microRNAs in cancer management. Lancet Oncol 2012; 13:e249-e258 [PMID: 22652233 DOI: 10.1016/S1470-2045(12)70073-6].
  • 8Bushati N, Cohen SM. microRNA functions. Annu Rev Cell DevBiol 2007; 23: 175-205 [PMID: 17506695].
  • 9Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, NochE, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T,Negrini M, Bullrich F, Croce CM. Frequent deletions and downregulationof micro- RNA genes miR15 and miR16 at 13q14 inchronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99:15524-15529 [PMID: 12434020].
  • 10Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, ShenJH, Xu LY, Li EM. Expression and prognostic significanceof THBS1, Cyr61 and CTGF in esophageal squamous cellcarcinoma. BMC Cancer 2009; 9: 291 [PMID: 19698122 DOI:10.1186/1471-2407-9-291].

共引文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部